Arcutis Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ARQT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Mar 24	BuyUS$199,994	Frazier Life Sciences Management, LP	Company	21,052	US$9.50
04 Mar 24	SellUS$38,568	Matthew Moore	Individual	3,468	US$11.12
04 Mar 24	BuyUS$199,994	Frazier Life Sciences Management, LP	Company	21,052	US$9.50
02 Jan 24	SellUS$4,692	Patrick Burnett	Individual	1,325	US$3.54
01 Dec 23	BuyUS$9,334	Todd Watanabe	Individual	1,463	US$6.38
21 Nov 23	SellUS$3,661	Masaru Matsuda	Individual	1,850	US$1.98
24 Oct 23	BuyUS$200,000	Frazier Life Sciences Management, LP	Company	80,000	US$2.50
21 Aug 23	SellUS$11,302	Patrick Burnett	Individual	1,605	US$7.05
31 May 23	SellUS$14,278	Masaru Matsuda	Individual	1,830	US$7.80

Insider Trading Volume

Insider Buying: ARQT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARQT?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	4,419	0.00383%
Individual Insiders	2,245,356	1.94%
General Public	2,571,190	2.23%
VC/PE Firms	8,785,291	7.6%
Hedge Funds	15,117,631	13.1%
Institutions	86,801,102	75.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 88.3%.

Top Shareholders

Top 25 shareholders own 83.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	Jennison Associates LLC	12,128,533	US$107.2m	33.8%	0.07%
7.6%	Frazier Life Sciences Management, LP	8,785,291	US$77.7m	0.24%	3.3%
7.33%	Suvretta Capital Management, LLC	8,473,101	US$74.9m	646%	3.2%
5.75%	Rubric Capital Management LP	6,644,530	US$58.7m	32%	1.88%
5.45%	Polar Capital Holdings Plc	6,297,688	US$55.7m	102%	0.24%
5.25%	Morgan Stanley, Investment Banking and Brokerage Investments	6,064,698	US$53.6m	2,810%	0.01%
5.12%	BlackRock, Inc.	5,916,546	US$52.3m	47.2%	no data
4.24%	The Vanguard Group, Inc.	4,896,513	US$43.3m	70.1%	no data
4.21%	Point72 Asset Management, L.P.	4,867,706	US$43.0m	1,040%	0.09%
4.03%	Franklin Resources, Inc.	4,655,544	US$41.2m	260%	0.02%
2.6%	Bain Capital Life Sciences Investors, LLC	3,000,000	US$26.5m	0%	2.49%
2.34%	Vestal Point Capital, LP	2,700,000	US$23.9m	0%	2.6%
2.25%	StemPoint Capital LP	2,594,536	US$22.9m	0%	6.46%
2.22%	Millennium Management LLC	2,558,880	US$22.6m	728%	0.02%
1.76%	Ensign Peak Advisors, Inc.	2,029,957	US$17.9m	146%	0.03%
1.7%	Opaleye Management Inc.	1,960,000	US$17.3m	0%	4.41%
1.65%	Pivotal BioVenture Partners LLC	1,910,009	US$16.9m	72.8%	6.75%
1.51%	Geode Capital Management, LLC	1,743,589	US$15.4m	68%	no data
1.42%	GW&K Investment Management, LLC	1,640,325	US$14.5m	-20.7%	0.13%
1.32%	State Street Global Advisors, Inc.	1,525,045	US$13.5m	-65%	no data
1.21%	Deutsche Asset & Wealth Management	1,394,410	US$12.3m	4,490%	0.01%
1.06%	FMR LLC	1,222,404	US$10.8m	-85.2%	no data
0.96%	Tejara Capital Limited., Asset Management Arm	1,112,217	US$9.8m	260%	3.76%
0.93%	Columbia Management Investment Advisers, LLC	1,079,580	US$9.5m	220%	no data
0.85%	Two Sigma Investments, LP	978,805	US$8.7m	0%	0.02%